Condition

Genetic Predisposition to Disease

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 27 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials27

Recruiting5

Common interventions25

Lead sponsors shown15

Clinical trials

27 shown

Expression of Genes Relating Hypertension and Efficacy of 4-7-8 Breathing Control on Reducing Blood PressureNCT07018128 · 2024-10-01

Microbiome and Association With Implant InfectionsNCT05020574 · 2021-09-28

Prostate Cancer Genetic Risk Evaluation and Screening StudyNCT05129605 · 2020-02-12

Blood Markers of Early Pancreas CancerNCT03568630 · 2018-07-26

Identification of Genomic Predictors of Adverse Events After Cardiac SurgeryNCT01258231 · 2000-08-01

Genetic Predisposition to High Blood PressureNCT07181213 · 2026-01-01

ENROLLING_BY_INVITATION

Prophylactic Prostatectomy for Prostate Cancer (PPPC)NCT06470685 · 2024-06-24

ENROLLING_BY_INVITATION

Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer PredispositionNCT05721326 · 2023-05-01

Mechanisms of Type 1 Diabetes EndophenotypesNCT05764850 · 2023-02-01

Full-scale Intervention Study: Genetic Risk Communication and WearablesNCT05524909 · 2022-11-01

The Relations Among Endotoxin, Inflammatory Cytokines, Cognitive Markers and Brain MRI Changes in Subjects With Depressive DisorderNCT06203015 · 2022-06-01

Intervention Study: Genetic Risk Communication and WearablesNCT04879758 · 2021-07-07

Family History and Breast Cancer Education TrialNCT05186727 · 2021-04-01

Surgical and Patient Reported Outcomes of Robotic Nipple-Sparing MastectomyNCT04151368 · 2019-11-01

Breast Cancer Risk After Diagnostic Gene SequencingNCT04145817 · 2019-10-22

Genetic of Response to Acute Saline Load Test in Hypertension (Naload)NCT04625569 · 2019-07-08

Genetic Determinants of Kidney Disease in People of African Ancestry With HIVNCT05685810 · 2018-05-01

ACTIVE_NOT_RECRUITING

Individual Variability of Appetite Responses to a Standardised MealNCT03771690 · 2018-01-11

Evaluating an Alternative Clinical Genetics Cancer Care Deliver ModelNCT03934606 · 2018-01-01

A Prognosis and Predicting Genetic Study of Lung CancerNCT03234179 · 2017-08-01

NOT_YET_RECRUITING

Telephone Versus Videoconference Communication for Remote Genetic Disclosure in the APOE4 TrialNCT02978729 · 2016-08-01

RORC Genetic Polymorphism of Rheumatoid ArthritisNCT03615729 · 2016-06-30

Genetic and Risk Factors in Exfoliation Glaucoma PatientsNCT06237764 · 2014-01-01

TCF7L2 Polymorphisms Influence on Glycemic Control in ICU Patients With Organ FailureNCT03055169 · 2012-04-01

4R for Guideline Indicated BRCA Testing of Breast Center PatientsNCT01320540 · 2011-03-01

Registry of Mastectomy for Breast Cancer Risk ReductionNCT00555503 · 2007-11-01

The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte CancerNCT00261456 · 2005-03-01

ACTIVE_NOT_RECRUITING

Common interventions

Leading sponsors

Abramson Cancer Center at Penn Medicine 2 The University of Hong Kong 2 Assiut University 1 Brigham and Women's Hospital 1 Burapha University 1 Georgetown University 1 Göteborg University 1 Institut Curie 1 Institute of Cancer Research, United Kingdom 1 King's College Hospital NHS Trust 1 Linkoeping University 1 Lithuanian University of Health Sciences 1 Loughborough University 1 Massachusetts General Hospital 1 National Taiwan University Hospital 1

Trial status mix

COMPLETED12

RECRUITING5

UNKNOWN4

ACTIVE_NOT_RECRUITING2

ENROLLING_BY_INVITATION2

NOT_YET_RECRUITING1

SUSPENDED1

Phase mix

NA10

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.